HPSE2 and diabetic kidney disease: In conclusion, we found that HPSE2 expression was downregulated in experimental glomerular disease models for glomerulonephritis, diabetic nephropathy and adriamycin nephropathy, a model for FSGS, which is suggested to be linked to the increased HPSE1 activity in these diseases.